VHT holdings (2026)
All 401 positions in Vanguard Health Care ETF, ranked by portfolio weight — led by LLY at 13.8%. Weights come from the fund's own SEC N-PORT filing and update daily with prices; positions in stocks ChartRow doesn't track still appear, ranked by weight, without returns. Not investment advice.
Weights are the May 31, 2026 SEC filing rolled forward on each holding's price move (as of market close, Aug 13, 2026) — an estimate of today, not the filed figure. Switch the table below to see them exactly as filed.
Top 10 holdings#
Sector weights#
Estimated portfolio characteristics#
Estimated by our own bottom-up analysis of the fund's SEC-filed holdings, covering 93% of portfolio weight (92% carries a valid trailing P/E). Funds publish similar figures on their own sites; ours are recomputed daily from public data.
VHT holdings by weight#
201–300 of 401| # | Company | Weight | Price | 1D | YTD | 1Y | Mkt cap |
|---|---|---|---|---|---|---|---|
| 201 | Recursion Pharmaceuticals Inc | 0.02% | — | — | — | — | — |
| 202 | Perrigo Co PLC | 0.02% | — | — | — | — | — |
| 203 | Innoviva Inc | 0.02% | — | — | — | — | — |
| 204 | Newamsterdam Pharma Co NV | 0.02% | — | — | — | — | — |
| 205 | Novavax Inc | 0.02% | — | — | — | — | — |
| 206 | Procept Biorobotics Corp | 0.02% | — | — | — | — | — |
| 207 | Ardelyx Inc | 0.02% | — | — | — | — | — |
| 208 | Mineralys Therapeutics Inc | 0.02% | — | — | — | — | — |
| 209 | Ocular Therapeutix Inc | 0.02% | — | — | — | — | — |
| 210 | Biohaven Ltd | 0.02% | — | — | — | — | — |
| 211 | Fortrea Holdings Inc | 0.02% | — | — | — | — | — |
| 212 | ANI Pharmaceuticals Inc | 0.02% | — | — | — | — | — |
| 213 | Alumis Inc | 0.02% | — | — | — | — | — |
| 214 | AtriCure Inc | 0.02% | — | — | — | — | — |
| 215 | Harmony Biosciences Holdings Inc | 0.02% | — | — | — | — | — |
| 216 | Vera Therapeutics Inc | 0.02% | — | — | — | — | — |
| 217 | NeoGenomics Inc | 0.02% | — | — | — | — | — |
| 218 | Nurix Therapeutics Inc | 0.02% | — | — | — | — | — |
| 219 | Trevi Therapeutics Inc | 0.02% | — | — | — | — | — |
| 220 | Teladoc Health Inc | 0.02% | — | — | — | — | — |
| 221 | LifeStance Health Group Inc | 0.02% | — | — | — | — | — |
| 222 | Enovis Corp | 0.02% | — | — | — | — | — |
| 223 | Enliven Therapeutics Inc | 0.02% | — | — | — | — | — |
| 224 | Iovance Biotherapeutics Inc | 0.02% | — | — | — | — | — |
| 225 | Stoke Therapeutics Inc | 0.02% | — | — | — | — | — |
| 226 | Establishment Labs Holdings Inc | 0.02% | — | — | — | — | — |
| 227 | Pennant Group Inc/The | 0.02% | — | — | — | — | — |
| 228 | Tandem Diabetes Care Inc | 0.02% | — | — | — | — | — |
| 229 | Inspire Medical Systems Inc | 0.02% | — | — | — | — | — |
| 230 | Pieris Pharmaceuticals Inc | 0.02% | — | — | — | — | — |
| 231 | CareDx Inc | 0.02% | — | — | — | — | — |
| 232 | Avanos Medical Inc | 0.02% | — | — | — | — | — |
| 233 | agilon health Inc | 0.02% | — | — | — | — | — |
| 234 | Viridian Therapeutics Inc | 0.02% | — | — | — | — | — |
| 235 | Rapport Therapeutics Inc | 0.02% | — | — | — | — | — |
| 236 | Vir Biotechnology Inc | 0.02% | — | — | — | — | — |
| 237 | AMN Healthcare Services Inc | 0.02% | — | — | — | — | — |
| 238 | CONMED Corp | 0.02% | — | — | — | — | — |
| 239 | UroGen Pharma Ltd | 0.02% | — | — | — | — | — |
| 240 | Harrow Inc | 0.02% | — | — | — | — | — |
| 241 | MannKind Corp | 0.02% | — | — | — | — | — |
| 242 | Collegium Pharmaceutical Inc | 0.02% | — | — | — | — | — |
| 243 | Kodiak Sciences Inc | 0.02% | — | — | — | — | — |
| 244 | Integra LifeSciences Holdings Corp | 0.01% | — | — | — | — | — |
| 245 | Nuvation Bio Inc | 0.01% | — | — | — | — | — |
| 246 | GeneDx Holdings Corp | 0.01% | — | — | — | — | — |
| 247 | Surgery Partners Inc | 0.01% | — | — | — | — | — |
| 248 | Xeris Biopharma Holdings Inc | 0.01% | — | — | — | — | — |
| 249 | EyePoint Inc | 0.01% | — | — | — | — | — |
| 250 | BioLife Solutions Inc | 0.01% | — | — | — | — | — |
| 251 | Schrodinger Inc/United States | 0.01% | — | — | — | — | — |
| 252 | New Issuer: BB Company ID:54419104 | 0.01% | — | — | — | — | — |
| 253 | Tango Therapeutics Inc | 0.01% | — | — | — | — | — |
| 254 | US Physical Therapy Inc | 0.01% | — | — | — | — | — |
| 255 | STAAR Surgical Co | 0.01% | — | — | — | — | — |
| 256 | AdaptHealth Corp | 0.01% | — | — | — | — | — |
| 257 | Azenta Inc | 0.01% | — | — | — | — | — |
| 258 | Pacira BioSciences Inc | 0.01% | — | — | — | — | — |
| 259 | Amylyx Pharmaceuticals Inc | 0.01% | — | — | — | — | — |
| 260 | New Issuer: BB Company ID:69588108 | 0.01% | — | — | — | — | — |
| 261 | Zymeworks Inc | 0.01% | — | — | — | — | — |
| 262 | Butterfly Network Inc | 0.01% | — | — | — | — | — |
| 263 | Alphatec Holdings Inc | 0.01% | — | — | — | — | — |
| 264 | Artivion Inc | 0.01% | — | — | — | — | — |
| 265 | QuidelOrtho Corp | 0.01% | — | — | — | — | — |
| 266 | Taysha Gene Therapies Inc | 0.01% | — | — | — | — | — |
| 267 | Kura Oncology Inc | 0.01% | — | — | — | — | — |
| 268 | Omeros Corp | 0.01% | — | — | — | — | — |
| 269 | AnaptysBio Inc | 0.01% | — | — | — | — | — |
| 270 | Precigen Inc | 0.01% | — | — | — | — | — |
| 271 | iRadimed Corp | 0.01% | — | — | — | — | — |
| 272 | Esperion Therapeutics Inc | 0.01% | — | — | — | — | — |
| 273 | KalVista Pharmaceuticals Inc | 0.01% | — | — | — | — | — |
| 274 | CryoPort Inc | 0.01% | — | — | — | — | — |
| 275 | Talkspace Inc | 0.01% | — | — | — | — | — |
| 276 | WaVe Life Sciences Ltd | 0.01% | — | — | — | — | — |
| 277 | MBX Biosciences Inc | 0.01% | — | — | — | — | — |
| 278 | Certara Inc | 0.01% | — | — | — | — | — |
| 279 | Amphastar Pharmaceuticals Inc | 0.01% | — | — | — | — | — |
| 280 | Aura Biosciences Inc | 0.01% | — | — | — | — | — |
| 281 | Corvus Pharmaceuticals Inc | 0.01% | — | — | — | — | — |
| 282 | Arbutus Biopharma Corp | 0.01% | — | — | — | — | — |
| 283 | Annexon Inc | 0.01% | — | — | — | — | — |
| 284 | Tilray Brands Inc | 0.01% | — | — | — | — | — |
| 285 | ArriVent Biopharma Inc | 0.01% | — | — | — | — | — |
| 286 | Phibro Animal Health Corp | 0.01% | — | — | — | — | — |
| 287 | CorMedix Inc | 0.01% | — | — | — | — | — |
| 288 | OPKO Health Inc | 0.01% | — | — | — | — | — |
| 289 | Castle Biosciences Inc | 0.01% | — | — | — | — | — |
| 290 | Monte Rosa Therapeutics Inc | 0.01% | — | — | — | — | — |
| 291 | MoonLake Immunotherapeutics | 0.01% | — | — | — | — | — |
| 292 | Theravance Biopharma Inc | 0.01% | — | — | — | — | — |
| 293 | Personalis Inc | 0.01% | — | — | — | — | — |
| 294 | Bicara Therapeutics Inc | 0.01% | — | — | — | — | — |
| 295 | Geron Corp | 0.01% | — | — | — | — | — |
| 296 | HealthStream Inc | 0.01% | — | — | — | — | — |
| 297 | Phreesia Inc | 0.01% | — | — | — | — | — |
| 298 | Cerus Corp | 0.01% | — | — | — | — | — |
| 299 | Xencor Inc | 0.01% | — | — | — | — | — |
| 300 | SI-BONE Inc | 0.01% | — | — | — | — | — |
Methodology#
Holdings and weights are sourced from the fund's portfolio as disclosed to the SEC on Form N-PORT — a public filing. Portfolio filings are quarterly (public ~60 days after quarter end), so we anchor on the latest one and roll each weight forward daily by that holding's price move, keeping the numbers current between filings; positions in stocks ChartRow doesn't track carry their filed weight unchanged and show "—" where we have no data. Returns are total returns (dividends reinvested). One row per company, not per ticker: when a fund holds more than one share class of the same company (Alphabet's GOOGL and GOOG, for example), we combine them into a single row whose weight is the sum of its classes. Past performance does not predict future returns; not investment advice.
FAQ#
- What are the top 10 holdings of VHT?
- VHT's top 10 holdings are Eli Lilly and Company (LLY), 13.8%; Johnson & Johnson (JNJ), 8.8%; AbbVie Inc. (ABBV), 6.3%; UnitedHealth Group Incorporated Common Stock (DE) (UNH), 5.1%; Merck & Co. Inc. (MRK), 4.8%; Amgen Inc. (AMGN), 3.2%; Thermo Fisher Scientific Inc. (TMO), 3.2%; Abbott Laboratories (ABT), 2.7%; Gilead Sciences Inc. (GILD), 2.4%; Pfizer Inc. (PFE), 2.2% — together about 52% of the fund, per its May 31, 2026 SEC filing with weights rolled forward to today.
- How many holdings does VHT have?
- Vanguard Health Care ETF (VHT) held 401 positions as of its latest SEC N-PORT filing (May 31, 2026).
- How current are VHT's holdings?
- Funds disclose their full portfolio to the SEC on Form N-PORT; the quarter-end report becomes public about 60 days later. ChartRow anchors on the latest public filing (May 31, 2026) and rolls each weight forward daily by that holding's price move, so the weights shown estimate today rather than the filing date.
- Is ChartRow affiliated with VHT or Vanguard?
- No. ChartRow is independent and is not affiliated with, sponsored by, or endorsed by Vanguard or Vanguard Health Care ETF. Everything on this page is derived independently from the fund's public SEC filings; fund names and trademarks belong to their owners. For information only — not investment advice.